The Lancet Oncology in conversation with
195 episodes - English - Latest episode: about 2 months ago - ★★★★★ - 1 ratingEditors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicity, and more.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Neuro-oncology: The Lancet Oncology, November 2015
November 02, 2015 08:15 - 5 minutes - 3.67 MBHideho Okada discusses immunotherapy response assessment criteria in neuro-oncology. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Metastatic breast cancer: The Lancet Oncology: Sept 10, 2015
September 10, 2015 15:15 - 8 minutes - 6.04 MBRajendra Badwe discusses treatment options for metastatic breast cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Breast cancer: The Lancet Oncology: Aug 6, 2015
August 11, 2015 23:15 - 10 minutes - 7.55 MBHarry Bear discusses the use of adjuvant and neoadjuvant bevacizumab in the treatment of early breast cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Watchful waiting for patients with rectal cancer: The Lancet Oncology: July 6, 2015
July 07, 2015 14:30 - 16 minutes - 11.5 MBAne Appelt discusses adopting a watchful waiting approach for patients with rectal cancer who achieved a clinical complete response after chemoradiotherapy. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
HPV vaccine dosing schedules: The Lancet Oncology: June 10, 2015
June 10, 2015 23:00 - 7 minutes - 5.1 MBAmy Kreimer discusses HPV vaccine dosing schedules and cervical cancer prevention. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
RANO Group: The Lancet Oncology: May 28, 2015
May 28, 2015 07:00 - 11 minutes - 8.14 MBNancy Lin discusses RANO Group’s new response assessment criteria checklist. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
HPV and cancer: The Lancet Oncology: April 30, 2015
April 30, 2015 15:15 - 17 minutes - 12.2 MBRolando Herrero summarises three papers that constitute the HPV and cancer Series. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Advances in cancer drug development: The Lancet Oncology: March 18, 2015
March 18, 2015 14:00 - 11 minutes - 7.65 MBJeffery Weber discuses advances in cancer drug development. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: March 02, 2015
March 02, 2015 08:15 - 13 minutes - 9.32 MBDr Saro Armenian discusses long term health concerns for survivors of childhood cancers. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: January 16, 2015
January 18, 2015 01:00 - 6 minutes - 4.81 MBJeff Bradley discusses standard verses high-dose radiation in conjunction with chemotherapy for patients with phase III non-small-cell lung cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: December 16, 2014
December 17, 2014 00:15 - 5 minutes - 3.78 MBDennis Slamon discusses advances in breast cancer treatment based on data from the PALOMA trial. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: November 24, 2014
November 24, 2014 08:00 - 15 minutes - 10.7 MBCharles Bennett discusses the development and regulatory landscape of biosimilar oncology drugs. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: October 27, 2014
October 27, 2014 21:00 - 7 minutes - 5.16 MBS Vincent Rajkumar of the Mayo Clinic discusses the updated disease definition of multiple myeloma. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: September 17, 2014
September 17, 2014 07:00 - 6 minutes - 4.2 MBDaniel M Green discusses the effect of treatment for childhood cancers on male fertility. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: August 28, 2014
August 28, 2014 15:00 - 9 minutes - 6.7 MBNaomi Lee discusses new research about depression and cancer with Michael Sharpe and Jane Walker. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: July 07, 2014
July 07, 2014 07:00 - 10 minutes - 7.2 MBRobert Hills discusses a meta-analysis of gemtuzumab ozogamicin for the treatment of adult myeloid leukaemia. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: June 30, 2014
June 30, 2014 07:00 - 13 minutes - 9.44 MBJeremy Whelan from the National Cancer Research Institute discusses the underrepresentation of teenagers and young adults in clinical cancer trials. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: May 27, 2014
May 27, 2014 07:00 - 6 minutes - 4.81 MBPaul Spiegel discusses cancer in refugees in Jordan and Syria and how the UNHCR have addressed the provision of expensive cancer treatment. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: May 05, 2014
May 05, 2014 07:00 - 13 minutes - 9.36 MBLaura Essermann discusses cancer over-diagnosis and over-treatment. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: May 02, 2014
May 02, 2014 07:00 - 9 minutes - 6.52 MBIan Krop discusses a phase III trial to assess efficacy of trastuzumab emtansine for women with recurrent HER2-positive breast cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: March 19, 2014
March 19, 2014 07:00 - 11 minutes - 7.75 MBMichael Höckel joins Natalie Harrison to discuss how surgery based on ontogenetic staging is sufficient to control cervical cancer without additional radiotherapy. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: February 07, 2014
February 07, 2014 08:00 - 11 minutes - 8.05 MBChristopher Klenk and Heike E Daldrup-Link join Natalie Harrison to discuss ionising radiation-free techniques in cancer detection. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: January 14, 2014
January 14, 2014 08:00 - 8 minutes - 5.69 MBJonathan Banks discusses the aims and implications of a study into public preferences for cancer testing. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: December 05, 2013
December 05, 2013 08:00 - 13 minutes - 9.52 MBRoberta de Angelis discusses the results and implications of the EUROCARE 5 study Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: November 11, 2013
November 11, 2013 08:00 - 15 minutes - 10.4 MBJayant Vaidya and Umberto Veronesi discuss the TARGIT and ELIOT trials of intraoperative radiotherapy for early breast cancer Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: October 14, 2013
October 14, 2013 07:00 - 8 minutes - 5.94 MBRamon Luengo-Fernandez discusses the cost of cancer care in the European Union. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: September 02, 2013
September 02, 2013 07:00 - 7 minutes - 5.11 MBJesus San Miguel discusses a phase 3 trial comparing pomalidomide plus low-dose dexamethasone with high-dose dexamethasone in patients with multiple myeloma. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: July 10, 2013
July 10, 2013 23:00 - 4 minutes - 3.23 MBOle Raaschou-Nielsen discusses the association between long-term exposure to ambient air pollution and lung cancer risk. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: June 07, 2013
June 07, 2013 07:00 - 10 minutes - 7.38 MBPerry Pickhardt discusses the value of CT colonography to determine whether small colorectal polyps will progress or not. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: May 15, 2013
May 15, 2013 07:00 - 11 minutes - 7.64 MBThorsten Kuehn discusses the SENTINA study, concerning centinel lymph node biopsy before and after neoadjuvant chemotherapy in breast cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: April 26, 2013
April 26, 2013 07:00 - 6 minutes - 4.79 MBPaul Goss presents an overview of The Lancet Oncology Commission on cancer prevention in Latin America. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: April 16, 2013
April 16, 2013 07:00 - 8 minutes - 5.78 MBYael Mosse discusses a phase I study about the potential of targeted molecular therapy for childhood cancers. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: April 03, 2013
April 03, 2013 07:00 - 11 minutes - 7.75 MBSulma Mohammed discusses a pilot study of breast cancer screening in rural Sudan. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: February 20, 2013
February 20, 2013 08:00 - 12 minutes - 8.31 MBKathy Pritchard-Jones discusses a Series about paediatric oncology. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: January 25, 2013
January 26, 2013 00:00 - 6 minutes - 4.71 MBJohn Farley discusses a trial of the MEK inhibitor selumetinib for the treatement of low-grade serous carcinoma of the ovary and peritoneum. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: December 04, 2012
December 04, 2012 08:00 - 8 minutes - 5.8 MBNicole Krekel discusses a trial which assesses ultrasound-guided breast conserving surgery in the management of breast cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: November 14, 2012
November 14, 2012 08:00 - 8 minutes - 5.73 MBAnticancer drugs: doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: October 30, 2012
October 30, 2012 07:00 - 12 minutes - 8.95 MBAsian Oncology Summit: Consensus guidelines on palliative care, kidney cancer, and colorectal cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: August 23, 2012
August 23, 2012 07:00 - 4 minutes - 2.93 MBDiscussion of a UK/French study into adult diabetes risk after radiation for childhood cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: August 06, 2012
August 06, 2012 07:00 - 4 minutes - 2.94 MBGustavo Ismael discusses subcutaneous versus intravenous administration of trastuzumab in patients with breast cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: July 13, 2012
July 13, 2012 07:00 - 9 minutes - 6.58 MBDiscussion of the oral MEK inhibitor trametinib in cancer treatment. . Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: June 06, 2012
June 06, 2012 07:00 - 9 minutes - 6.61 MBCirculating tumour cells as a possible prognostic marker for non-metastatic breast cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: May 01, 2012
May 01, 2012 07:00 - 15 minutes - 10.8 MBMatthias Kloor discusses the prevalence of mismatch repair-deficient crypt foci in Lynch syndrome. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: March 23, 2012
March 23, 2012 07:00 - 8 minutes - 6.07 MBAndrew Grulich discusses his paper looking at HPV infection and anal cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: February 22, 2012
February 22, 2012 08:00 - 7 minutes - 4.93 MBThe association between endometriosis and ovarian cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: February 10, 2012
February 10, 2012 08:00 - 10 minutes - 7.56 MBThe effect of chemotherapy in pregnancy on health outcomes in young children. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: January 30, 2012
January 30, 2012 08:00 - 9 minutes - 6.49 MBDiscussion of updated guidelines for the appropriate use of opioids in the management of cancer pain. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: November 25, 2011
November 25, 2011 08:00 - 14 minutes - 9.97 MBHLA matching of transplanted umbilical-cord blood for treating leukaemia and myelodysplastic syndrome. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: November 14, 2011
November 14, 2011 08:00 - 6 minutes - 4.64 MBComparison of CT colonography with conventional colonoscopy for colorectal cancer screening. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: October 28, 2011
October 28, 2011 07:00 - 11 minutes - 8.22 MBDiscussion of a promising antiangiogenic approach for the treatment of ovarian cancer, and other highlights from the November issue. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv